IS5251A - 9-oxime erythromycin derivatives - Google Patents

9-oxime erythromycin derivatives

Info

Publication number: IS5251A
Authority: IS; Iceland
Prior art keywords: erythromycin derivatives; oxime erythromycin; oxime; derivatives; erythromycin
Prior art date: 1997-06-11

Application number

IS5251A

Other languages

Icelandic (is)

Inventor

Wu Yong-Jin

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-11

Filing date

1999-11-16

Publication date

1999-11-16

1999-11-16 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

1999-11-16 Publication of IS5251A publication Critical patent/IS5251A/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Genetics & Genomics (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

IS5251A 1997-06-11 1999-11-16 9-oxime erythromycin derivatives IS5251A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4934997P	1997-06-11	1997-06-11
PCT/IB1998/000741 WO1998056800A1 (en)	1997-06-11	1998-05-15	9-oxime erythromycin derivatives

Publications (1)

Publication Number	Publication Date
IS5251A true IS5251A (en)	1999-11-16

Family

ID=21959341

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5251A IS5251A (en)	1997-06-11	1999-11-16	9-oxime erythromycin derivatives

Country Status (31)

Country	Link
EP (1)	EP0988308A1 (en)
JP (1)	JP2000513026A (en)
KR (1)	KR20010013660A (en)
CN (1)	CN1259135A (en)
AP (1)	AP9801253A0 (en)
AR (1)	AR012244A1 (en)
AU (1)	AU7226798A (en)
BG (1)	BG103947A (en)
BR (1)	BR9810021A (en)
CA (1)	CA2293335A1 (en)
CO (1)	CO4940506A1 (en)
CZ (1)	CZ9904388A3 (en)
EA (1)	EA199901016A1 (en)
GT (1)	GT199800074A (en)
HN (1)	HN1998000073A (en)
HR (1)	HRP980316A2 (en)
HU (1)	HUP0002252A3 (en)
ID (1)	ID24529A (en)
IL (1)	IL132767A0 (en)
IS (1)	IS5251A (en)
MA (1)	MA26505A1 (en)
NO (1)	NO996108L (en)
OA (1)	OA11225A (en)
PA (1)	PA8451801A1 (en)
PE (1)	PE79899A1 (en)
PL (1)	PL337606A1 (en)
TN (1)	TNSN98083A1 (en)
TR (1)	TR199902995T2 (en)
TW (1)	TW448174B (en)
WO (1)	WO1998056800A1 (en)
ZA (1)	ZA985018B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HN1998000159A (en) *	1997-10-29	1999-02-09	Monsanto Co	DERIVATIVES OF 9- AMINO - 3 CETO ERITROMICINA
ES2243066T3 (en) *	1998-09-22	2005-11-16	Pfizer Products Inc.	CARBAMATE AND CETOLID CARBAZATE ANTIBIOTICS.
FR2786188B1 (en) *	1998-11-24	2002-10-31	Hoechst Marion Roussel Inc	NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US6258785B1 (en)	1998-12-02	2001-07-10	Pfizer Inc.	Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) *	1998-12-10	2006-11-02	Pfizer Products Inc.	Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) *	1998-12-18	2001-09-04	Bio-Rad Laboratories, Inc.	Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
ATE340183T1 (en) *	1999-04-16	2006-10-15	Kosan Biosciences Inc	ANTINIFECTIVE MACROLIDE DERIVATIVES
HUP0201516A3 (en)	1999-05-24	2003-03-28	Pfizer Prod Inc	13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
EP1181300B1 (en) *	1999-06-07	2003-09-17	Abbott Laboratories	6-o-carbamate ketolide derivatives
ID27331A (en) *	1999-09-29	2001-03-29	Pfizer Prod Inc	MAKING ANTIBIOTIC-ANTIBIOTIC KETOLIDA CARBAMATE
EP1114826A3 (en) *	1999-12-29	2001-10-31	Pfizer Products Inc.	Novel antibacterial and prokinetic macrolides
EP1439186A3 (en) *	1999-12-29	2004-11-03	Pfizer Products Inc.	Intermediates for novel antibacterial and prokinetic macrolides
US6946446B2 (en)	2000-02-24	2005-09-20	Abbott Laboratories	Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en)	2000-07-05	2002-06-11	Pfizer Inc.	Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) *	2002-04-25	2003-11-06	Abbott Laboratories	9-oxime macrolide antibacterials
TW200420573A (en)	2002-09-26	2004-10-16	Rib X Pharmaceuticals Inc	Bifunctional heterocyclic compounds and methods of making and using same
EP1638549A4 (en) *	2003-03-10	2011-06-15	Optimer Pharmaceuticals Inc	NEW ANTIBACTERIAL AGENTS
EP1723159B1 (en)	2004-02-27	2019-06-12	Melinta Therapeutics, Inc.	Macrocyclic compounds and methods of making and using the same
EP2214484A4 (en)	2007-10-25	2013-01-02	Cempra Pharmaceuticals Inc	PROCESS FOR THE PREPARATION OF MACROLIDE ANTIBACTERIAL AGENTS
JP5711135B2 (en)	2008-10-24	2015-04-30	センプラファーマシューティカルズ，インコーポレイテッド	Methods for treating gastrointestinal disorders
US9937194B1 (en)	2009-06-12	2018-04-10	Cempra Pharmaceuticals, Inc.	Compounds and methods for treating inflammatory diseases
ES2608285T3 (en)	2009-09-10	2017-04-07	Cempra Pharmaceuticals, Inc.	Procedures for the treatment of malaria, tuberculosis and MAC diseases
CN102146085B (en) *	2010-02-09	2014-03-26	北京理工大学	9-oxime-ether ketolide derivative, and preparation method and medical composite thereof
MX361413B (en)	2010-03-22	2018-12-05	Cempra Pharmaceuticals Inc Star	Crystalline forms of a macrolide, and uses therefor.
CN102917708B (en)	2010-05-20	2015-11-25	森普拉制药公司	Process for preparing macrolides and ketolides and intermediates thereof
EP2613630A4 (en)	2010-09-10	2014-01-15	Cempra Pharmaceuticals Inc	FLUOROCETOLIDES FORMING HYDROGEN LINKS TO TREAT DISEASES
NZ700182A (en)	2012-03-27	2017-02-24	Cempra Pharmaceuticals Inc	Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en)	2013-03-14	2015-10-01	Cempra Pharmaceuticals, Inc.	Methods for treating respiratory diseases and formulations therefor
CN105188712A (en)	2013-03-15	2015-12-23	森普拉制药公司	Astringent method for preparing macrolide antibacterial agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL99995A (en) *	1990-11-21	1997-11-20	Roussel Uclaf	Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) *	1992-11-05	1996-06-18	Roussel Uclaf	Erythromycin derivatives
FR2718450B1 (en) *	1994-04-08	1997-01-10	Roussel Uclaf	New erythromycin derivatives, their preparation process and their use as drugs.

1998
- 1998-05-15 EP EP98919394A patent/EP0988308A1/en not_active Withdrawn
- 1998-05-15 ID IDW991570A patent/ID24529A/en unknown
- 1998-05-15 KR KR1019997011672A patent/KR20010013660A/en not_active Ceased
- 1998-05-15 IL IL13276798A patent/IL132767A0/en unknown
- 1998-05-15 CN CN98805848A patent/CN1259135A/en active Pending
- 1998-05-15 CZ CZ19994388A patent/CZ9904388A3/en unknown
- 1998-05-15 BR BR9810021-1A patent/BR9810021A/en not_active IP Right Cessation
- 1998-05-15 HU HU0002252A patent/HUP0002252A3/en unknown
- 1998-05-15 EA EA199901016A patent/EA199901016A1/en unknown
- 1998-05-15 WO PCT/IB1998/000741 patent/WO1998056800A1/en not_active Ceased
- 1998-05-15 TR TR1999/02995T patent/TR199902995T2/en unknown
- 1998-05-15 PL PL98337606A patent/PL337606A1/en unknown
- 1998-05-15 JP JP11501928A patent/JP2000513026A/en active Pending
- 1998-05-15 CA CA002293335A patent/CA2293335A1/en not_active Abandoned
- 1998-05-15 AU AU72267/98A patent/AU7226798A/en not_active Abandoned
- 1998-05-19 HN HN1998000073A patent/HN1998000073A/en unknown
- 1998-05-21 PA PA19988451801A patent/PA8451801A1/en unknown
- 1998-06-04 AP APAP/P/1998/001253A patent/AP9801253A0/en unknown
- 1998-06-05 GT GT199800074A patent/GT199800074A/en unknown
- 1998-06-08 PE PE1998000470A patent/PE79899A1/en not_active Application Discontinuation
- 1998-06-08 TW TW087109086A patent/TW448174B/en active
- 1998-06-09 AR ARP980102703A patent/AR012244A1/en unknown
- 1998-06-10 ZA ZA9805018A patent/ZA985018B/en unknown
- 1998-06-10 MA MA25105A patent/MA26505A1/en unknown
- 1998-06-10 TN TNTNSN98083A patent/TNSN98083A1/en unknown
- 1998-06-11 CO CO98033538A patent/CO4940506A1/en unknown
- 1998-06-11 HR HR60/049,349A patent/HRP980316A2/en not_active Application Discontinuation
1999
- 1999-11-16 IS IS5251A patent/IS5251A/en unknown
- 1999-12-03 BG BG103947A patent/BG103947A/en unknown
- 1999-12-03 OA OA9900269A patent/OA11225A/en unknown
- 1999-12-10 NO NO996108A patent/NO996108L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO996108D0 (en)	1999-12-10
CN1259135A (en)	2000-07-05
CZ9904388A3 (en)	2002-10-16
AR012244A1 (en)	2000-09-27
HUP0002252A3 (en)	2002-01-28
BR9810021A (en)	2000-09-19
HUP0002252A2 (en)	2000-12-28
GT199800074A (en)	1999-11-27
CA2293335A1 (en)	1998-12-17
BG103947A (en)	2000-07-31
TW448174B (en)	2001-08-01
CO4940506A1 (en)	2000-07-24
ID24529A (en)	2000-07-20
OA11225A (en)	2003-07-17
MA26505A1 (en)	2004-12-20
PL337606A1 (en)	2000-08-28
PA8451801A1 (en)	2000-05-24
WO1998056800A1 (en)	1998-12-17
KR20010013660A (en)	2001-02-26
JP2000513026A (en)	2000-10-03
HRP980316A2 (en)	1999-04-30
EA199901016A1 (en)	2000-06-26
TNSN98083A1 (en)	2005-03-15
TR199902995T2 (en)	2000-02-21
PE79899A1 (en)	1999-08-25
HN1998000073A (en)	1999-01-08
AU7226798A (en)	1998-12-30
NO996108L (en)	2000-02-10
IL132767A0 (en)	2001-03-19
AP9801253A0 (en)	1999-12-04
ZA985018B (en)	1999-12-10
EP0988308A1 (en)	2000-03-29

Publication	Publication Date	Title
IS5251A (en)	1999-11-16	9-oxime erythromycin derivatives
ATE310742T1 (en)	2005-12-15	C-4ß-SUBSTITUTED MACROLIDE DERIVATIVES
ATE377018T1 (en)	2007-11-15	ERYTHROMYCIN DERIVATIVES
IS5528A (en)	2000-06-09	New macrolide
NO993876D0 (en)	1999-08-11	3'-N-oxide, 3'-N-dimethylamine, 9-oxime erythromycin A derivatives
DE69919769D1 (en)	2004-10-07	3,6-ketal macrolide antibiotics
NO20015172D0 (en)	2001-10-23	1-Methyl erythromycin derivatives
IS5919A (en)	2001-04-17	New macrolide antibiotics
DK1027362T3 (en)	2005-10-31	2-halo-6-O-substituted ketolide derivatives
ATE257484T1 (en)	2004-01-15	6,9-BRIDGED ERYTHROMYCIN DERIVATIVES
ATE239750T1 (en)	2003-05-15	6,11-BRIDGED ERYTHROMYCIN DERIVATIVES
NO980016D0 (en)	1998-01-02	Macrolides
EP1167375A4 (en)	2002-10-30	ERYTHROMYCIN DERIVATIVES
LV11898A (en)	1997-12-20	Erythromycin derivatives
EP0766685A4 (en)	1997-07-16	MACROLIDES ARYLES, ALKYLES, ALCENYLES ET ALCYNYLES
ZA983902B (en)	1999-11-08	Erythromycin derivatives.
EP1044985A4 (en)	2001-04-18	ERYTHROMYCIN DERIVATIVES
PT984975E (en)	2003-09-30	MULTICICULAR ERYTHROMYCIN DERIVATIVES
BR1100453A (en)	2006-05-09	erythromycin derivatives
GB9700702D0 (en)	1997-03-05	Erythromycin derivatives
ZA989845B (en)	1999-04-29	2-halo-6-O-substituted ketolide derivatives
SI1027362T1 (en)	2005-12-31	2-halo-6-o-substituted ketolide derivatives
FI971952A0 (en)	1997-05-07	Antibiotic aemne